Data / Form D filings / Tetrous, Inc.
Tetrous, Inc.: Form D filings
Tetrous, Inc., a biotechnology company in Sherman Oaks, CA, filed 3 Form D notices with the SEC between 2023 and 2026. The latest, on April 22, 2026, reports $1.7 million sold of a $4 million offering to 64 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 14930 VENTURA BLVD., SUITE 325, Sherman Oaks, CA, 91324
- Phone
- (818) 645-4081
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2002357
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | New notice | $4,000,000 | $1,741,024 | $2,258,976 | 64 | Apr 8, 2026 | sec.gov |
| Dec 22, 2023 | Amendment | $5,000,000 | $444,639 | $4,555,361 | 2 | Dec 12, 2023 | sec.gov |
| Dec 21, 2023 | New notice | $5,000,000 | $444,639 | $4,555,361 | 2 | Dec 12, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bradley E. Patt | Executive Officer, Director | |
| Gunnar Andersson | Director | |
| Simon Berry | Director | |
| John Bojanowski | Director | |
| Matthew Muscio | Director | |
| Jan Iwanczyk | Director | |
| Frank Philips | Director | |
| Andy Carter | Director | |
| Nikhil Verma | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Apr 20, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Tetrous, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.